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were chosen when closeness of the PTV to the bowel was 
intermediate and doses were 5 x 6.5/9.0/11.0 Gy to 
SIP/main/SIB PTV. 12 fraction regimens were preferred in 
patients with large contact interfaces to bowel OARs and 
doses were 12 x 3.5/4.0/5.0 Gy to SIP/main/SIB PTV. If in 
doubt, a plan for 5 fractions was created and if dose 
constraints were violated a new plan for 12 fractions was 
made. Original dose constraints for OARs for 12 fractions 
were recalculated using EQD2 (equivalent dose in 2 Gy 
fractions) with α/β 3 for late bowel toxicity in an attempt to 
achieve isotoxicity. Proton pump inhibitors (PPI) were 
prescribed prior to SBRT for at least 6 months after 
completion of therapy. 
Results: Since 08/2013 25 patients with the SIB-SIP concept 
were treated with hepatic metastases, primary hepatic 
lesions, Klatskin tumours and pancreatic cancer (PDAC). Most 
often SIP-volumes were small compared to the main PTV and 
14 patients could be treated with 5 fractions, whereas in 11 
patients a 12 fraction regimen was preferred. Acute toxicity 
was < grade 2 in 23 patients. One patient with PDAC had 
grade 3 pain after the 1st of planned 5 fractions which did not 
re-occur after change to the 12-fraction-regimen single 
doses. One patient with PDAC had Forrest grade III gastric 
ulceration after 24/48 Gy (main PTV) despite prophylactic PPI 
intake. None of the patients developed late gastrointestinal 
complications >= grade 2 after a median follow-up of 9 
months and local control rate at 9 months was 81%. 
Conclusions: We here present a novel ICRU-type prescription 
technique for upper abdominal SBRT combining protection of 
bowel OARs with directed boost to the core regions of the 
lesion with favourable initial clinical tolerance and local 
tumour efficacy.  
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Purpose/Objective: The purpose of this study was to analyze 
intra-fractional positioning uncertainty for stereotactic 
radiotherapy and radiosurgery of cranial tumors, including 
primary brain tumors and metastatic disease. Specifically, we 
wish to determine if the use of intra-fractional image guided 
patient positioning verification is necessary during delivery of 
'frameless' stereotactic radiotherapy and radiosurgery 
(SRT/SRS) and non-coplanar radiation beams, and if 
positioning uncertainty is associated with overall treatment 
time.  
Materials and Methods: The patients were treated on an 
accelerator-based stereotactic equipment (NovalisTx with 
micoMLC, Varian/BrainLab). Orthogonal radiographic 
treatment verification data was extracted for 288 
consecutive patients and 1344 fractions, and were analyzed 
with respect to 3D translational and angular corrections once 
during treatment delivery of SRT/SRS (ExacTrac, BrainLab). 
The treatment position was adjusted using 6D corrections 
(Robotics, BrainLab). Association was investigated using 
Spearman signed rank test and p-values less than 0.05 were 
considered significant.  
Results: The study shows that positioning corrections greater 
than 2 mm are required for ca. 6% of the beams (see Fig.1). 
Further, the magnitude of the translational corrections and 
the maximum angular deviations were both significantly 
associated with the delay time between the beams (p<0.006) 
(see Table 1). In addition, the maximum angular and 
translational deviations were associated (p<0.001).  
Table 1. Spearman correlation coefficients for the treatment 
beams investigated.  
 
Parameter Association Rho 
Significance  
(2-tailed) 
Lateral dev. Long. dev. -0.007 0.785 
Vertical dev. Long. dev. -0.039 0.157 
Lateral dev. Vertical dev. -0.012 0.672 
Max angular dev. Delay time 0.092 0.006 
3D deviation Delay time 0.376 0.000 
3D deviation 
Max angular 
dev. 
0.174 0.000 
 
Conclusions: We conclude that a subgroup of SRT/SRS 
patients may have considerable positioning error unless this is 
monitored and corrected during treatment, and that keeping 
the imaging and delivery times short is beneficial towards 
clinically relevant geographical misses.  
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Purpose/Objective: To identify the main pitfalls and 
challenges and their possible sources in clinical target volume 
